Iqvia Holdings Inc (NYSE:IQV) Director Michael J. Evanisko sold 816 shares of Iqvia stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $100.00, for a total value of $81,600.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of Iqvia Holdings Inc (NYSE:IQV) traded down $0.84 during mid-day trading on Wednesday, reaching $104.84. The company’s stock had a trading volume of 1,111,427 shares, compared to its average volume of 1,186,370. The company has a market capitalization of $22,062.05, a P/E ratio of 17.33, a P/E/G ratio of 2.71 and a beta of 0.64. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.19 and a current ratio of 1.19. Iqvia Holdings Inc has a 1-year low of $76.80 and a 1-year high of $110.67.
Iqvia (NYSE:IQV) last issued its earnings results on Wednesday, February 14th. The medical research company reported $1.32 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.34 by ($0.02). The business had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.09 earnings per share. research analysts predict that Iqvia Holdings Inc will post 2.84 EPS for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. bought a new stake in shares of Iqvia during the fourth quarter valued at approximately $1,364,000. Colonial Trust Advisors bought a new stake in shares of Iqvia during the fourth quarter valued at approximately $5,550,000. Xact Kapitalforvaltning AB bought a new stake in shares of Iqvia during the fourth quarter valued at approximately $4,054,000. Envestnet Asset Management Inc. bought a new stake in shares of Iqvia during the fourth quarter valued at approximately $1,497,000. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp bought a new stake in shares of Iqvia during the fourth quarter valued at approximately $7,838,000. Hedge funds and other institutional investors own 92.34% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://stocknewstimes.com/2018/03/14/michael-j-evanisko-sells-816-shares-of-iqvia-holdings-inc-iqv-stock.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.